Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Refsum

Showing results (21-30 of 276) with videos related to

Pageof 28
Sort By:
Acta Pharmacologica Et Toxicologica|April 1, 1977
The effect of calcium and beat interval on the contractile force and refractoriness of the isolated rat atrium in the absence and presence of nifedipine: a possible mechanism for the negative staircase phenomenonK Landmark, H Refsum
Acta Pharmacologica Et Toxicologica|January 1, 1973
Competitive antagonism between phenoxybenzamine and acetylcholine in isolated rat atriaH Refsum, K Landmark
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 30, 1990
[Sotalol. Beta-blockade and class III antiarrhythmic effect]H Bjørnstad, H Refsum
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2003
Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalaminH Refsum, A D Smith
Nordisk Medicin|January 1, 1989
[Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy]P M Ueland, H Refsum
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1984
Vagus- and post-acetylcholine-induced changes in ventricular electrophysiology of the dog heart with and without beta-blockadeJ P Amlie, H Refsum
Pharmacology & Toxicology|January 1, 1990
Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitroP M Tande, H Refsum
Trends in Pharmacological Sciences|October 1, 1990
Clinical significance of pharmacological modulation of homocysteine metabolismH Refsum, P M Ueland
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Dementia Prevention by Disease-Modification through NutritionA D Smith, H Refsum
Current Opinion in Lipidology|December 30, 1998
Recent data are not in conflict with homocysteine as a cardiovascular risk factorH Refsum, P M Ueland
Pageof 28

Showing results (21-30 of 276) with videos related to

Sort By:
Pageof 28
Acta Pharmacologica Et Toxicologica|April 1, 1977
The effect of calcium and beat interval on the contractile force and refractoriness of the isolated rat atrium in the absence and presence of nifedipine: a possible mechanism for the negative staircase phenomenonK Landmark, H Refsum
Acta Pharmacologica Et Toxicologica|January 1, 1973
Competitive antagonism between phenoxybenzamine and acetylcholine in isolated rat atriaH Refsum, K Landmark
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 30, 1990
[Sotalol. Beta-blockade and class III antiarrhythmic effect]H Bjørnstad, H Refsum
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2003
Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalaminH Refsum, A D Smith
Nordisk Medicin|January 1, 1989
[Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy]P M Ueland, H Refsum
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1984
Vagus- and post-acetylcholine-induced changes in ventricular electrophysiology of the dog heart with and without beta-blockadeJ P Amlie, H Refsum
Pharmacology & Toxicology|January 1, 1990
Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitroP M Tande, H Refsum
Trends in Pharmacological Sciences|October 1, 1990
Clinical significance of pharmacological modulation of homocysteine metabolismH Refsum, P M Ueland
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Dementia Prevention by Disease-Modification through NutritionA D Smith, H Refsum
Current Opinion in Lipidology|December 30, 1998
Recent data are not in conflict with homocysteine as a cardiovascular risk factorH Refsum, P M Ueland
Pageof 28